• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达ras癌基因的NIH 3T3成纤维细胞中的细胞骨架重组。

Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.

作者信息

Dartsch P C, Ritter M, Häussinger D, Lang F

机构信息

Physiologisches Institut (I), Universität Tübingen, Germany.

出版信息

Eur J Cell Biol. 1994 Apr;63(2):316-25.

PMID:8082656
Abstract

Expression of the Ha-ras oncogene in NIH 3T3 fibroblasts leads to a set point shift of cell volume regulation and causes an increase in cell volume by activation of Na+/H+ exchange and Na+, K+, 2Cl- cotransport. Since both ion transport systems are thought to be governed by the cytoskeleton, the aim of this study was to examine the alterations in growth characteristics and cytoskeletal organization due to the expression of the oncogene. The experiments were performed on NIH 3T3 fibroblasts transfected with a transforming Ha-ras MMTV-LTR construct and expressing the oncogene after treatment with low serum medium and 1 mumol/l dexamethasone (+ras cells). Transfected cells not expressing the oncogene (-ras cells) and treated with low serum medium, but without the addition of dexamethasone, served as controls. The growth characteristics were examined and the cytoskeletal architecture was visualized by indirect immunofluorescence microscopy using specific antibodies and fluorescent dyes. Expression of the ras oncogene was accompanied by a significant and serum-independent increase in proliferative activity irrespective from the coating of the dishes with attachment factors (poly-L-lysine, collagen type I). Both, -ras and +ras cells, proliferated slower on substrates coated with poly-L-lysine than on tissue culture plastic or collagen type I. Expression of the ras oncogene also resulted in a significant increase in cell volume which was independent from the substrate. +ras Cells became more elongated, exhibited long cytoplasmic protrusions and tended to detach when compared with -ras cells. Examination of the cytoskeletal architecture in +ras and -ras cells revealed marked differences such as a depolymerization of the stress fiber network to strongly fluorescent "focals" as well as the absence of vinculin-containing attachment plaques (focal contacts), a disorganization of non-muscle myosin and of cell surface fibronectin in +ras cells. In addition, a retraction of microtubules and vimentin filaments to the perinuclear region was also observed in +ras cells. For comparison, NIH 3T3 fibroblasts which were not transfected with the ras oncogene (0ras cells) and which were also subjected to the experimental conditions described above (low serum medium +/- dexamethasone), did not exhibit the cytoskeletal alterations as observed for +ras cells. The results demonstrate that the expression of ras oncogene causes not only profound alterations in the proliferative activity, cell volume and cell morphology, but also a marked reorganization of cytoskeletal architecture, which may participate in the altered regulation of volume-regulatory ion transporters in the cell membrane.

摘要

Ha-ras癌基因在NIH 3T3成纤维细胞中的表达导致细胞体积调节的设定点偏移,并通过激活Na⁺/H⁺交换和Na⁺、K⁺、2Cl⁻协同转运使细胞体积增加。由于这两种离子转运系统都被认为受细胞骨架调控,本研究的目的是检测由于癌基因表达导致的生长特性和细胞骨架组织的改变。实验在转染了转化型Ha-ras MMTV-LTR构建体并在低血清培养基和1 μmol/L地塞米松处理后表达癌基因的NIH 3T3成纤维细胞(+ras细胞)上进行。未表达癌基因的转染细胞(-ras细胞)用低血清培养基处理,但不添加地塞米松,作为对照。检测生长特性,并使用特异性抗体和荧光染料通过间接免疫荧光显微镜观察细胞骨架结构。ras癌基因的表达伴随着增殖活性显著且不依赖血清的增加,无论培养皿是否用附着因子(聚-L-赖氨酸、I型胶原)包被。-ras和+ras细胞在聚-L-赖氨酸包被的底物上增殖均比在组织培养塑料或I型胶原上慢。ras癌基因的表达还导致细胞体积显著增加,且与底物无关。与 -ras细胞相比,+ras细胞变得更加细长,表现出长的细胞质突起,并且易于脱离。对+ras和 -ras细胞的细胞骨架结构检查发现了明显差异,如应力纤维网络解聚为强荧光的“焦点”以及不含纽蛋白的附着斑(粘着斑)缺失,+ras细胞中非肌肉肌球蛋白和细胞表面纤连蛋白的紊乱。此外,在+ras细胞中还观察到微管和波形蛋白丝向核周区域的回缩。作为对照,未转染ras癌基因的NIH 3T3成纤维细胞(0ras细胞)也接受上述实验条件(低血清培养基+/-地塞米松)处理,未表现出如+ras细胞所观察到的细胞骨架改变。结果表明,ras癌基因的表达不仅导致增殖活性、细胞体积和细胞形态的深刻改变,还导致细胞骨架结构的显著重组,这可能参与了细胞膜中体积调节离子转运体的调节改变。

相似文献

1
Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.表达ras癌基因的NIH 3T3成纤维细胞中的细胞骨架重组。
Eur J Cell Biol. 1994 Apr;63(2):316-25.
2
Activation of Na+/H(+)-exchanger by transforming Ha-ras requires stimulated cellular calcium influx and is associated with rearrangement of the actin cytoskeleton.通过转化型Ha-ras激活钠/氢交换体需要刺激细胞钙内流,且与肌动蛋白细胞骨架的重排有关。
Eur J Cell Biol. 1997 Mar;72(3):222-8.
3
Effects of calcium channel blockers on NIH 3T3 fibroblasts expressing the Ha-ras oncogene.
Eur J Cell Biol. 1995 Aug;67(4):372-8.
4
Ultrastructural cytoskeleton alterations and modification of actin expression in the NIH/3T3 cell line after transformation with Ha-ras-activated oncogene.
Cell Motil Cytoskeleton. 1990;15(4):220-9. doi: 10.1002/cm.970150405.
5
Increased cell-substrate adhesion accompanies conditional reversion to the normal phenotype in ras-oncogene-transformed NIH-3T3 cells.
Exp Cell Res. 1994 Oct;214(2):440-6. doi: 10.1006/excr.1994.1280.
6
Expression of alpha 1-chimaerin (rac-1 GAP) alters the cytoskeletal and adhesive properties of fibroblasts.α1-嵌合蛋白(rac-1 GAP)的表达改变了成纤维细胞的细胞骨架和黏附特性。
J Cell Biochem. 1994 Dec;56(4):582-91. doi: 10.1002/jcb.240560419.
7
Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.转化生长因子β1部分抑制ras转化的肝细胞的转化表型。
Cell Growth Differ. 1992 Oct;3(10):693-704.
8
Ca2+ and Zn2+ dependence of DNA synthesis in untransformed and in Ha-ras(val-12)-expressing NIH 3T3 cells.
Exp Cell Res. 1993 Sep;208(1):303-10. doi: 10.1006/excr.1993.1250.
9
Motility of intracellular particles in rat fibroblasts is greatly enhanced by phorbol ester and by over-expression of normal p21N-ras.佛波酯和正常p21N-ras的过表达可大大增强大鼠成纤维细胞内颗粒的运动性。
Cell Motil Cytoskeleton. 1993;25(3):254-66. doi: 10.1002/cm.970250306.
10
Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.来自c-H-ras癌基因转化的NIH 3T3细胞的隐性(中介体-)回复突变体:裸鼠中的致瘤性以及培养中回收的肿瘤细胞的短暂锚定非依赖性和血清非依赖性
J Cell Physiol. 1991 Nov;149(2):214-21. doi: 10.1002/jcp.1041490207.

引用本文的文献

1
From Pinocytosis to Methuosis-Fluid Consumption as a Risk Factor for Cell Death.从胞饮作用到“methuosis”——液体摄取作为细胞死亡的一个风险因素
Front Cell Dev Biol. 2021 Jun 23;9:651982. doi: 10.3389/fcell.2021.651982. eCollection 2021.
2
The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction.RAS 和 RHO 信号通路在细胞转化、迁移和收缩中的交汇点。
Genes (Basel). 2021 May 27;12(6):819. doi: 10.3390/genes12060819.
3
Up-regulation of Orai1 expression and store operated Ca(2+) entry following activation of membrane androgen receptors in MCF-7 breast tumor cells.
MCF-7乳腺癌细胞中膜雄激素受体激活后Orai1表达上调及钙库操纵性钙内流
BMC Cancer. 2015 Dec 21;15:995. doi: 10.1186/s12885-015-2014-2.
4
Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro.细胞松弛素类似物、微管导向剂和阿霉素单独或联合应用对人卵巢癌细胞系的体外作用。
BMC Cancer. 2015 Sep 10;15:632. doi: 10.1186/s12885-015-1619-9.
5
Ion channels in cancer: future perspectives and clinical potential.癌症中的离子通道:未来展望与临床潜力
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 3;369(1638):20130108. doi: 10.1098/rstb.2013.0108. Print 2014 Mar 19.
6
H-ras-transformed NRK-52E renal epithelial cells have altered growth, morphology, and cytoskeletal structure that correlates with renal cell carcinoma in vivo.H-ras 转化的 NRK-52E 肾上皮细胞具有改变的生长、形态和细胞骨架结构,这与体内肾细胞癌相关。
In Vitro Cell Dev Biol Anim. 1999 Apr;35(4):205-14. doi: 10.1007/s11626-999-0028-2.
7
Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton.非典型蛋白激酶C-λ和非典型蛋白激酶C-ζ参与Ras介导的F-肌动蛋白细胞骨架重组的证据。
J Cell Biol. 1999 Feb 8;144(3):413-25. doi: 10.1083/jcb.144.3.413.
8
A role for Rho in Ras transformation.Rho在Ras转化中的作用。
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11781-5. doi: 10.1073/pnas.92.25.11781.
9
Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity.法尼基转移酶抑制剂通过干扰Rho活性来抑制Ras转化的证据。
Mol Cell Biol. 1995 Dec;15(12):6613-22. doi: 10.1128/MCB.15.12.6613.